You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Auxilium Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for AUXILIUM PHARMS, and when can generic versions of AUXILIUM PHARMS drugs launch?

AUXILIUM PHARMS has nine approved drugs.

There is one US patent protecting AUXILIUM PHARMS drugs.

There are forty-five patent family members on AUXILIUM PHARMS drugs in twenty-nine countries.

Summary for Auxilium Pharms
International Patents:45
US Patents:1
Tradenames:10
Ingredients:7
NDAs:9

Drugs and US Patents for Auxilium Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc ROBAXIN-750 methocarbamol TABLET;ORAL 011011-006 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Auxilium Pharms Llc THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943-004 Feb 28, 1992 RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Auxilium Pharms Llc THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943-002 Aug 22, 1983 RX No No ⤷  Try a Trial ⤷  Try a Trial
Auxilium Pharms Llc DILATRATE-SR isosorbide dinitrate CAPSULE, EXTENDED RELEASE;ORAL 019790-001 Sep 2, 1988 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Auxilium Pharms Llc THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943-003 Aug 22, 1983 RX No No ⤷  Try a Trial ⤷  Try a Trial
Auxilium Pharms Llc LEVATOL penbutolol sulfate TABLET;ORAL 018976-004 Jan 5, 1989 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Auxilium Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 8,178,518 ⤷  Try a Trial
Auxilium Pharms Llc SEMPREX-D acrivastine; pseudoephedrine hydrochloride CAPSULE;ORAL 019806-001 Mar 25, 1994 4,501,893 ⤷  Try a Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 7,935,690 ⤷  Try a Trial
Auxilium Pharms Llc STRIANT testosterone TABLET, EXTENDED RELEASE;BUCCAL 021543-001 Jun 19, 2003 4,615,697 ⤷  Try a Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 7,608,607 ⤷  Try a Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 7,608,610 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for AUXILIUM PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Gel 1% ➤ Subscribe 2008-08-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.